Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Clear all

503 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
20016
200227
200314
20047
200514
200619
200717
200820
200936
201027
201142
201238
201331
201430
201521
201618
201710
20189
201911
20207
202114
202210
202312
20248
202512
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed386
Unknown status37
Terminated27
Recruiting23
Withdrawn17
Not yet recruiting10
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim80
GlaxoSmithKline65
AstraZeneca58
Novartis Pharmaceuticals46
Pearl Therapeutics, Inc.18
Chiesi Farmaceutici S.p.A.16
Novartis12
Henan University of Traditional Chinese Medicine8
Sanofi8
Sumitomo Pharma America, Inc.8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive503
Emphysema30
Bronchitis, Chronic21
Lung Diseases19
Lung Diseases, Obstructive15
Dyspnea13
Respiratory Tract Diseases10
Asthma8
Hypertension, Pulmonary7
Bronchitis5

Trials

Showing 1 to 25 of 503. Each trial links to its page on Pharma Observatory.

403 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.